By Spy Uganda
African countries face a last-ditch battle against the third wave of Covid infections, as the supply of vaccines to the continent “grinds to a halt”, top health officials have warned.
“The threat of a third wave in Africa is real and rising. Our priority is clear – it’s crucial that we swiftly get vaccines into the arms of Africans at high risk of falling seriously ill and dying of Covid-19,” said Dr Matshidiso Moeti, the World Health Organization (WHO) regional director for Africa.
The WHO said the pandemic was now trending upwards in 14 countries and in the past week alone, eight countries had witnessed an abrupt rise of over 30% in cases. However, vaccine shipments to African nations have ground to a near halt.
“While many countries outside Africa have now vaccinated their high-priority groups and are able to even consider vaccinating their children, African countries are unable to even follow up with second doses for high-risk groups,” Moeti said.
Only 50m doses have been received in Africa, of which 31 million doses had been administered in 50 countries with a combined population of more than a billion.
Africa has officially registered almost 5m Covid-19 cases and more than 130,000 deaths, a figure representing 2.9% of global cases and 3.7% of deaths, but many experts believe the total is a very significant underestimate, and that the death toll is likely to be many times higher.
The UN-backed Covax vaccine-sharing facility that many African countries hoped would ensure equitable access worldwide has failed to provide more than a tiny fraction of the shots needed, as rich nations buy up all available supplies and Indian producers of the favoured AstraZeneca vaccine service only local demand.
Burkina Faso, which has a population of 20 million, this week received just 115,000 doses from the Covax Facility, while Rwanda and Togo each received about 100,000 Pfizer vaccine doses. In Zimbabwe, hundreds of people are being turned away from vaccination centres as the country’s supplies of China’s Sinovac vaccine appear to have run out.
Infections are also surging in Angola, Namibia and the Democratic Republic of the Congo, where 32 members of parliament and several aides to the president, Félix Tshisekedi, are among those who have died.
Uganda, which has received only a third of 3m vaccines expected from Covax, recorded a 131% week-on-week rise last week, with infection clusters in schools, rising cases among health workers and isolation centres and intensive care units filling up.
The country’s president, Yoweri Museveni, further toughened virus curbs on Sunday night, ordering the closure of schools for six weeks and banning most gatherings.
Uganda has counted 52,935 cases of coronavirus, of which 383 have been fatal, figures believed to be undercounted as a result of low testing.
“In this wave, the intensity of severe and critically ill Covid-19 patients, and deaths are higher than what we experienced in the first wave of the pandemic,” Museveni said in a televised address.
“We are concerned that this will exhaust available bed space and oxygen supply in hospitals unless we constitute urgent public health measures,” said Museveni.
Such shortages are almost universal. In a survey last month, the WHO found health facilities and personnel crucial for critically ill Covid patients are grossly inadequate in many African countries.
Of 23 countries surveyed, it found that most had less than one intensive care unit (ICU) bed per 100,000 population and only one-third had mechanical ventilators.
By comparison, rich countries such as Germany and the United States have more than 25 ICU beds per 100,000 people.
“Treatment is the last line of defence against this virus and we cannot let it be breached,” Moeti told reporters, calling for better equipment for the hospital and medical staff.
Tanzania, Burundi, Chad and Eritrea are yet to start any vaccination campaign. There has been a resurgence of infection in Seychelles despite it being the most vaccinated country in Africa, possibly due to new variants and the relatively low efficacy of China’s Sinopharm vaccine.